172 related articles for article (PubMed ID: 16579478)
1. [Hepatitis E virus of different genotypes contains multiple-type antigenic epitopes].
Deng L; Meng JH; Zhao Y; Zhang HM; Dai X
Wei Sheng Wu Xue Bao; 2006 Feb; 46(1):120-6. PubMed ID: 16579478
[TBL] [Abstract][Full Text] [Related]
2. Characterization of antigenic epitopes of the ORF2 protein from hepatitis E virus genotype 4.
Zhang H; Dai X; Shan X; Meng J
Virus Res; 2009 Jun; 142(1-2):140-3. PubMed ID: 19428747
[TBL] [Abstract][Full Text] [Related]
3. [Identification of a novel antigenic epitope on GST fusion-expressed and ORF2-encoded proteins of hepatitis E virus].
Liang JH; Liang LM; Dong M; Han ZG; Dong C; Meng JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Apr; 24(4):321-3, 327. PubMed ID: 18394332
[TBL] [Abstract][Full Text] [Related]
4. [Characterization of antigenic epitopes of ORF2 encoded proteins of hepatitis E virus genotype 4 identified in China].
Zhang HM; Dai X; Meng JH; Zhao Y; Shan XN
Yi Chuan; 2007 May; 29(5):637-42. PubMed ID: 17548336
[TBL] [Abstract][Full Text] [Related]
5. A single amino acid substitution changes antigenicity of ORF2-encoded proteins of hepatitis E virus.
Liang JH; Dai X; Dong C; Meng JH
Int J Mol Sci; 2010 Aug; 11(8):2962-75. PubMed ID: 21152284
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity difference between two hepatitis E vaccines derived from genotype 1 and 4.
Wen J; Behloul N; Dai X; Dong C; Liang J; Zhang M; Shi C; Meng J
Antiviral Res; 2016 Apr; 128():36-42. PubMed ID: 26850829
[TBL] [Abstract][Full Text] [Related]
7. [The preliminary analysis of the recognition epitopes of anti-HEV monoclonal antibodies on HEV ORF2].
Xiong JH; Guo QS; Ge SX; Gu Y; Chen YX; Miao J; Du HL; Shi WG; Zhang J; Xia NS
Bing Du Xue Bao; 2008 Jun; 24(2):83-7. PubMed ID: 18533338
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of human (genotype 1) and swine (genotype 4)-ORF2-based ELISAs for anti-HEV IgM and IgG detection in an endemic country and search for type 4 human HEV infections.
Arankalle VA; Lole KS; Deshmukh TM; Chobe LP; Gandhe SS
J Viral Hepat; 2007 Jun; 14(6):435-45. PubMed ID: 17501765
[TBL] [Abstract][Full Text] [Related]
9. An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4.
Zhou YH; Purcell RH; Emerson SU
Vaccine; 2004 Jun; 22(20):2578-85. PubMed ID: 15193383
[TBL] [Abstract][Full Text] [Related]
10. Generation in yeast and antigenic characterization of hepatitis E virus capsid protein virus-like particles.
Simanavicius M; Tamosiunas PL; Petraityte-Burneikiene R; Johne R; Ulrich RG; Zvirbliene A; Kucinskaite-Kodze I
Appl Microbiol Biotechnol; 2018 Jan; 102(1):185-198. PubMed ID: 29143081
[TBL] [Abstract][Full Text] [Related]
11. Varying abilities of recombinant polypeptides from different regions of hepatitis E virus ORF2 and ORF3 to detect anti-HEV immunoglobulin M.
Ma H; Song X; Li Z; Harrison TJ; Zhang H; Huang W; Hao W; Kong W; Wang Y
J Med Virol; 2009 Jun; 81(6):1052-61. PubMed ID: 19382255
[TBL] [Abstract][Full Text] [Related]
12. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.
Renoux VM; Fleury MJ; Bousarghin L; Gaitan J; Sizaret PY; Touzé A; Coursaget P
Vaccine; 2008 Dec; 26(51):6602-7. PubMed ID: 18835319
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis E virus ORF3 antigens derived from genotype 1 and 4 viruses are detected with varying efficiencies by an anti-HEV enzyme immunoassay.
Ma H; Song X; Harrison TJ; Zhang H; Huang W; Wang Y
J Med Virol; 2011 May; 83(5):827-32. PubMed ID: 21360543
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of two linear epitope motifs in hepatitis E virus ORF2 protein.
Wang H; Zhang W; Gu H; Chen W; Zeng M; Ji C; Song R; Zhang G
PLoS One; 2017; 12(9):e0184947. PubMed ID: 28957334
[TBL] [Abstract][Full Text] [Related]
15. Production of monoclonal antibodies against hepatitis E virus capsid protein and evaluation of their neutralizing activity in a cell culture system.
Takahashi M; Hoshino Y; Tanaka T; Takahashi H; Nishizawa T; Okamoto H
Arch Virol; 2008; 153(4):657-66. PubMed ID: 18266052
[TBL] [Abstract][Full Text] [Related]
16. [Antigencity identification of recombinant hepatitis E virus ORF2 protein expressed in Pichia pastoris].
Tong YP; Bi SL; Lu J; Jiang YZ; Zhan MY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):258-61. PubMed ID: 15340572
[TBL] [Abstract][Full Text] [Related]
17. [Selection of a peptide mimic the neutralization epitope of hepatitis E virus with phage peptide display technology].
Gu Y; Zhang J; Wang YB; Li SW; Yang HJ; Luo WX; Xia NS
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):680-5. PubMed ID: 15971579
[TBL] [Abstract][Full Text] [Related]
18. A Proline-Rich Domain in the Genotype 4 Hepatitis E Virus ORF3 C-Terminus Is Crucial for Downstream V105DLP108 Immunoactivity.
Wang H; Ji F; Liang H; Gu H; Ning Z; Liu R; Zhang G
PLoS One; 2015; 10(7):e0133282. PubMed ID: 26177202
[TBL] [Abstract][Full Text] [Related]
19. Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein.
Zhang J; Gu Y; Ge SX; Li SW; He ZQ; Huang GY; Zhuang H; Ng MH; Xia NS
Vaccine; 2005 Apr; 23(22):2881-92. PubMed ID: 15780737
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a Competitive Binding Assay Identifying the Different Characteristics of Neutralizing Epitopes of Hepatitis E Virus.
Wen J; Lu W; Liu Z; Meng J
Intervirology; 2017; 60(5):190-195. PubMed ID: 29510392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
